Earnings (Loss) Per Share (Tables)

12 Months Ended

Mar. 31, 2026

Earnings (Loss) Per Share [Abstract]

Schedule of Outstanding Shares for Basic and Diluted Net Earnings Per Share

The following table details the outstanding shares for basic and diluted net earnings per share:

	For the years ended March 31,
	2026			2025			2024
Numerator:
Net loss from continuing operation attributable to Akso Health Group’s shareholder	$	(18,671,610	)	$	(134,977,369	)	$	(9,058,986	)
Net loss from discontinued operation attributable to Akso Health Group’s shareholders		—			——			(399,798	)
Net loss attributable to Akso Health Group’s shareholders	$	(18,671,610	)	$	(134,977,369	)	$	(9,458,784	)
Denominator:
Weighted average number of ordinary shares outstanding—basic		2,168,121,761			855,288,335			141,516,777
Weighted average number of dilutive potential ordinary shares from share options		—			—			—
Weighted average number of ordinary shares outstanding—diluted		2,168,121,761			855,288,335			141,516,777
Basic (loss) per common share	$	(0.01	)	$	(0.16	)	$	(0.07	)
Diluted (loss) per common share	$	(0.01	)	$	(0.16	)	$	(0.07	)